Hemogenyx Pharmaceuticals Share Discussion Threads

[ernestsyngen] 06/3/2018 11:51

These are Golden Hold shares. Look at the videos, this is NOT an AIM Punt share. It is a medium to Long Term hold. Some derampers on here have not got an Fffing clue about it. BUY AND HOLD ( this is the thing most people seem NOT to be able to handle)

[billthebank] 06/3/2018 11:44

So as I said they have plenty of cash at present and they are in discussions with potential partners!!!! No conjecture from em about what may or may not happen between now and the lock in period

[the stigologist] 06/3/2018 11:34

They have cash for now (£3m?) but the time at which they should start to think about placing to raise more cash is about the same time their 12 month lock-in ends so they'd better have good news to ramp it then otherwise expect this to plummet

[billthebank] 06/3/2018 11:34

They have plenty of cash at the moment so no need to fund raise and they are actively pursuing a partner at present. This share could easily drop but likewise it could rise. An announcement of a partner and who knows.

[genises] 06/3/2018 11:31

How much cash do they have in the bank.
No doubt fund raising will be required to substane trials until stage three.
Looks like at least two years before product will come to market,unless one of the bigger boys buys it.

[moneytree1] 06/3/2018 11:02

riff raff chancers and loonies slowly getting cleared.

will be a good re-entry for the more savvy in the coming months.atb

[sidjameslaugh] 06/3/2018 11:00

I’d say stig is spot on. 4.14 to sell. Not much interest except from people who bought and failed to sell on the spike.

[lodgeview] 06/3/2018 10:59

Plummeting again. All the way back to 2p.

[tsmith2] 06/3/2018 10:16

Stig - sounding increasingly desperate.

[ernestsyngen] 06/3/2018 09:11

Hemo like sending RNS's and like above, I think more good news is due very soon indeed. It would not surprise me if we hear of " game changing" news in the next week or two. Dr Sheppard has been recruited for a reason and is associated with good Companies. He would not have joined unless it boots his reputation.

[the patient investor] 06/3/2018 08:36

yep, to me that is the true great news

[andrbea] 06/3/2018 08:35

And he's sold on a string of embryo companies to majors, in the past.

[the patient investor] 06/3/2018 08:34

also, the timing of his involvement must mean something is brewing and we may be close to further great news, you don't involve such a great figure just like that.

There is definitely something round the corner.
Often good RNSs lead to even better ones.

[ernestsyngen] 06/3/2018 08:32

Dr Shepard is a superb name for Hemo to have working for them. He knows this business very well indeed.

[the patient investor] 06/3/2018 08:31

thanks hattie1

I am a former scientist in a very different field (bacteria in plant pathology) and I often used to see great minds who sadly had limited business acumen and a disconnection with the industry.

This guy seems to have both a great brain and business intelligence in large amounts!


Meanwhile the MMs are playing their usual games scaring people as they certainly expect a huge demand for this share which, good for us, is very very illiquid.

I can easily see 10p in a few months.

[hattie1] 06/3/2018 08:24

As a former Oncology nurse I'm very impressed at this appointment especially as Dr Shepard was involved with herceptin which has massive benefits for breast cancer patients ...

[113mike] 06/3/2018 08:18

nor is 3p by the looks of it!

[the patient investor] 06/3/2018 08:12

this is much more remarkable than it seems.

this guy is not just a top scientist but somebody who helped creating multibillion selling new cutting edge drugs. He has already all the right contacts in the industry. To me this RNS is worth in itself 2-3p at least.

I am not saying it is as if a small IT company had acquired the combined services of Steve Jobs and Steve Wozniak but the comparison is not too far away.

this will make our tiny company super attractive to the big pharmas

10p is not far

[cudmore] 06/3/2018 07:48

Great news. Onwards and upwards!

[orchestralis] 06/3/2018 07:31

Commenting Dr. Shepard, said: "Hemogenyx is developing cancer therapies that have the potential to save lives, and I'm proud to be a part of that. As a member of Hemogenyx's Scientific Advisory Board, I'll be able to use the experience I've accrued working with other pre-clinical biotechnology programmes to help guide Hemogenyx toward the release of successful antibody-based therapies."

[lufc5] 05/3/2018 22:52

Oh they are, they really are.

[buddugoliaeth] 05/3/2018 21:16

humanised mice alone must be worth a bomb